# Progress Note 05 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Annie Oakley (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI021-SYN
- Date: 2026-07-06
- Fictional facility: St. Posthumous Health Center
- Fictional author: Ruth Ellingsen, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Five-month pernicious anemia, iron, and back pain review. **S**

## History of present illness

Mrs. Oakley returns for her five-month review. She has had her monthly B12 injection each month, the latest a week ago, and takes iron every other day with mild constipation, managed with fruit and fluids. Her colonoscopy in May showed only a few diverticula. Her bladder infection in May cleared with nitrofurantoin. Her energy is normal and she teaches two full shooting classes a week and walks a mile a day. The tingling in her feet is gone, with slight numbness only at the tips of the great toes. Back pain is mild most days; she takes naproxen about twice a month after long days at the range. She has had no falls. **S**

| Element | Detail |
|---|---|
| Interval change | Back to full teaching; tingling gone |
| Adherence | Monthly injections on schedule; iron every other day |
| Colonoscopy | A few diverticula only |
| Back pain | Mild; naproxen about twice a month |
| Falls | None |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy normal; weight stable |
| Gastrointestinal | Positive | Mild constipation on iron; no black stools, indigestion, or bleeding |
| Genitourinary | Negative | Cystitis resolved |
| Neurological | Positive | Slight numbness at the tips of the great toes; balance normal |
| Musculoskeletal | Positive | Mild low back ache after long days standing |

5 systems reviewed. **S**

## Current medications

- Cyanocobalamin 1000 micrograms (1 mL) intramuscular injection once a month, lifelong **S**
- Ferrous sulfate 325 mg oral tablet (65 mg elemental iron), one tablet by mouth every other day with orange juice **S**
- Naproxen sodium 220 mg oral tablet, one tablet by mouth with food up to twice daily as needed for back pain flares **S**

## Allergies

- No known allergy **S**

## Objective

BP 122/72 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 99% on room air; weight 47.8 kg; BMI 20.7 kg/m². All vital signs are synthetic.

Hemoglobin: 13.1 g/dL; MCV: 92 fL; White cell count: 5.8 10*3/uL; Platelets: 262 10*3/uL; Ferritin: 48 ng/mL; Transferrin saturation: 24%; Back pain, 0 to 10: 3; Oswestry Disability Index (percent): 16. All results are synthetic.

## Change since baseline

- Hemoglobin: 8.9 g/dL (low) at baseline, 13.1 g/dL at this visit **S**
- MCV: 114 fL (high) at baseline, 92 fL at this visit **S**
- White cell count: 3.6 10*3/uL (low) at baseline, 5.8 10*3/uL at this visit **S**
- Platelets: 128 10*3/uL (low) at baseline, 262 10*3/uL at this visit **S**
- Ferritin: 52 ng/mL at baseline, 48 ng/mL at this visit **S**
- Transferrin saturation: 34% at baseline, 24% at this visit **S**
- Back pain, 0 to 10: 5 at baseline, 3 at this visit **S**
- Oswestry Disability Index (percent): 28 at baseline, 16 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well |
| Neurological | Vibration mildly reduced at the great toes; proprioception and ankle reflexes normal; Romberg negative |
| Back | Minimal paraspinal tenderness; full range of motion |
| Gait | Steady, slight limp; Timed Up and Go 10 seconds |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Pernicious anemia in remission on monthly B12** (D51.0). Hemoglobin 13.1 g/dL and MCV 92 fL. The neuropathy has nearly resolved, with mild residual loss of vibration at the great toes. **S**
   - Continue monthly injections for life.
   - No repeat B12 level.
   - Blood count yearly.
2. **Iron deficiency, improving** (E61.1). Ferritin 48 ng/mL and transferrin saturation 24 percent after three months, just below the target of 50 ng/mL. The colon examination found no bleeding source. **S**
   - Continue alternate-day iron for three more months.
   - Blood count and ferritin in three months.
3. **Chronic low back pain, controlled** (M54.50). Pain 3 of 10 and Oswestry score 16 percent, with function restored. **S**
   - Continue the home program and tai chi.
   - Naproxen only for occasional flares.
4. **Autoimmune atrophic gastritis** (K29.40). No upper GI symptoms. **S**
   - Surveillance endoscopy in about three years.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | Blood count | Every 3 months for a year on oral iron; yearly in pernicious anemia | Completed today | Hemoglobin 13.1 g/dL, MCV 92 fL, white cells 5.8, platelets 262 |
| Laboratory | Iron studies | At the end of the iron course | Completed today | Ferritin 48 ng/mL, transferrin saturation 24 percent; continue iron to a ferritin of at least 50 |
| Laboratory | Blood count about one month after starting oral iron | Once, about four weeks after starting oral iron | Deferred | Not drawn: the month passed with the colonoscopy and the May sick visit, and no draw was ordered, a deviation from the CMID schedule. Today's hemoglobin 13.1 g/dL and ferritin 48 ng/mL show a good response, so no harm resulted. The three-month check is now a standing order |
| Laboratory | Serum B12 | Not routinely retested once replacement has begun | Not indicated | Not repeated |
| Examination | Neurologic examination (vibration, proprioception, gait, cognition) | At diagnosis and at follow-up visits for B12 deficiency with neurologic findings | Completed today | Nearly resolved: vibration mildly reduced at the great toes only |
| Medication safety | Injection adherence | Every visit | Completed today | Monthly injections on schedule; the latest a week ago |
| Imaging | Colonoscopy for iron deficiency | Once | Up to date | Done in May: diverticula only |
| Imaging | Surveillance endoscopy | About every 3 years for advanced atrophic gastritis | Due | In about three years |
| Survey | Back pain intensity and Oswestry Disability Index | Every visit while treating chronic low back pain | Completed today | Pain 3 of 10; Oswestry 16 percent |
| Medication safety | NSAID safety | Each visit | Completed today | About two doses a month with food; no GI symptoms |
| Survey | Depression screen (PHQ-2) | Periodically | Due | At the preventive visit later this month |
| Examination | Fall risk | Every visit while neuropathy persists | Completed today | Timed Up and Go 10 seconds; no falls |

## Goal progress

- Normal hemoglobin and MCV within eight weeks of starting B12 replacement. Outcome by 2026-04-06: Hemoglobin 12.3 g/dL and MCV 96 fL at eight weeks. **S**
- Stop the progression of neuropathy and recover balance, with no falls. Outcome by 2026-07-06: Paresthesia gone, Romberg negative, vibration mildly reduced at the great toes only; no falls. **S**
- Reduce back pain to 3 of 10 or less and the Oswestry score below 20 percent by the five-month review. Outcome by 2026-07-06: Pain 3 of 10 and Oswestry 16 percent. **S**
- Return to teaching full shooting classes. Outcome by 2026-07-06: Teaching two full classes a week. **S**

## Guideline basis

- Guidelines for the diagnosis and treatment of cobalamin and folate disorders (2014), British Society for Haematology
- AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency Anemia (2020), American Gastroenterological Association
- Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians (2017), American College of Physicians
- CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026), Aether Forge

## Follow-up

- Monthly B12 injections. Preventive visit later this month. Blood count and ferritin in three months. **S**
- Next scheduled visit 2026-07-27: adult preventive visit. **S**
